BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18678292)

  • 1. Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment.
    Annala AP; Karjalainen PP; Porela P; Nyman K; Ylitalo A; Airaksinen KE
    Am J Cardiol; 2008 Aug; 102(4):386-90. PubMed ID: 18678292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radial versus femoral access for orally anticoagulated patients.
    Ziakas AG; Koskinas KC; Gavrilidis S; Giannoglou GD; Hadjimiltiades S; Gourassas I; Theofilogiannakos E; Economou F; Styliadis I
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):493-9. PubMed ID: 20882651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin.
    Baker NC; O'Connell EW; Htun WW; Sun H; Green SM; Skelding KA; Blankenship JC; Scott TD; Berger PB
    Am Heart J; 2014 Oct; 168(4):537-44. PubMed ID: 25262264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular access site complication in transfemoral coronary angiography between uninterrupted warfarin and heparin bridging.
    Wongcharoen W; Pinyosamosorn K; Gunaparn S; Boonnayhun S; Thonghong T; Suwannasom P; Phrommintikul A
    J Interv Cardiol; 2017 Aug; 30(4):387-392. PubMed ID: 28664579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?
    Page SP; Siddiqui MS; Finlay M; Hunter RJ; Abrams DJ; Dhinoja M; Earley MJ; Sporton SC; Schilling RJ
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):265-70. PubMed ID: 21040095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.
    Karjalainen PP; Vikman S; Niemelä M; Porela P; Ylitalo A; Vaittinen MA; Puurunen M; Airaksinen TJ; Nyman K; Vahlberg T; Airaksinen KE
    Eur Heart J; 2008 Apr; 29(8):1001-10. PubMed ID: 18346963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
    Li HK; Chen FC; Rea RF; Asirvatham SJ; Powell BD; Friedman PA; Shen WK; Brady PA; Bradley DJ; Lee HC; Hodge DO; Slusser JP; Hayes DL; Cha YM
    Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of manual pressure hemostasis following transfemoral coronary angiography in patients on therapeutic warfarin anticoagulation.
    El-Jack SS; Ruygrok PN; Webster MW; Stewart JT; Bass NM; Armstrong GP; Ormiston JA; Pornratanarangsi S
    Am J Cardiol; 2006 Feb; 97(4):485-8. PubMed ID: 16461042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of safety between continued warfarin therapy and bridging anticoagulation therapy in patients undergoing coronary intervention].
    Zhang XJ; Yan HB; Chi YP; Zhao QM; Tian L; Zhang M; Wang GZ; Zhang XX; Chen Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jul; 46(7):549-553. PubMed ID: 30032546
    [No Abstract]   [Full Text] [Related]  

  • 11. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
    Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
    Kiviniemi T; Karjalainen P; Pietilä M; Ylitalo A; Niemelä M; Vikman S; Puurunen M; Biancari F; Airaksinen KE
    Am J Cardiol; 2012 Jul; 110(1):30-5. PubMed ID: 22464216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin.
    Kim JS; Jongnarangsin K; Latchamsetty R; Chugh A; Ghanbari H; Crawford T; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):302-9. PubMed ID: 23443620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of radial artery occlusion after transradial access in patients receiving warfarin therapy and undergoing coronary angiography.
    Pancholy SB; Ahmed I; Bertrand OF; Patel T
    Am J Cardiol; 2014 Jan; 113(2):211-4. PubMed ID: 24210677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
    Jessup DB; Coletti AT; Muhlestein JB; Barry WH; Shean FC; Whisenant BK
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):180-4. PubMed ID: 14517922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment?
    Lahtela H; Karjalainen PP; Niemelä M; Vikman S; Kervinen K; Ylitalo A; Puurunen M; Porela P; Nyman K; Hinkka-Yli-Salomäki S; Airaksinen KE
    Thromb Haemost; 2009 Dec; 102(6):1227-33. PubMed ID: 19967155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.